A citation-based method for searching scientific literature

Limin Zhang, Yan Wang, Chao Zhao, Jinpeng Shi, Sha Zhao, Xiaozhen Liu, Yijun Jia, Tao Zhu, Tao Jiang, Xuefei Li, Caicun Zhou. Onco Targets Ther 2019
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Feasibility of cytological specimens for ALK fusion detection in patients with advanced NSCLC using the method of RT-PCR.
Yan Wang, Yu Liu, Chao Zhao, Xuefei Li, Chunyan Wu, Likun Hou, Shijia Zhang, Tao Jiang, Xiaoxia Chen, Chunxia Su,[...]. Lung Cancer 2016
11
66

Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.
Christine M Lovly, Abha Gupta, Doron Lipson, Geoff Otto, Tina Brennan, Catherine T Chung, Scott C Borinstein, Jeffrey S Ross, Philip J Stephens, Vincent A Miller,[...]. Cancer Discov 2014
223
33

Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
Bella Bielorai, Moshe Leitner, Gal Goldstein, Ruty Mehrian-Shai, Luba Trakhtenbrot, Tamar Fisher, Victoria Marcu, Michal Yalon, Ginette Schiby, Ortal Barel,[...]. Acta Haematol 2019
5
33

Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Adrián Mariño-Enríquez, Wei-Lien Wang, Angshumoy Roy, Dolores Lopez-Terrada, Alexander J F Lazar, Christopher D M Fletcher, Cheryl M Coffin, Jason L Hornick. Am J Surg Pathol 2011
181
33

Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Siraj M Ali, Thomas Hensing, Alexa B Schrock, Justin Allen, Eric Sanford, Kyle Gowen, Atul Kulkarni, Jie He, James H Suh, Doron Lipson,[...]. Oncologist 2016
81
33

Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
Cristina R Antonescu, Albert J H Suurmeijer, Lei Zhang, Yun-Shao Sung, Achim A Jungbluth, William D Travis, Hikmat Al-Ahmadie, Christopher D M Fletcher, Rita Alaggio. Am J Surg Pathol 2015
160
33

A Screening Method for the ALK Fusion Gene in NSCLC.
Yoshiko Murakami, Tetsuya Mitsudomi, Yasushi Yatabe. Front Oncol 2012
60
33

The use of quantitative real-time reverse transcriptase PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancers.
Rui Wang, Yunjian Pan, Chenguang Li, Haichuan Hu, Yang Zhang, Hang Li, Xiaoyang Luo, Jie Zhang, Zhaoyuan Fang, Yuan Li,[...]. Clin Cancer Res 2012
68
33

ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
Hidetaka Yamamoto, Akihiko Yoshida, Kenichi Taguchi, Kenichi Kohashi, Yui Hatanaka, Atsushi Yamashita, Daisuke Mori, Yoshinao Oda. Histopathology 2016
105
33

Novel ALK fusion partners in lung cancer.
Aglaya G Iyevleva, Grigory A Raskin, Vladislav I Tiurin, Anna P Sokolenko, Natalia V Mitiushkina, Svetlana N Aleksakhina, Aigul R Garifullina, Tatiana N Strelkova, Valery O Merkulov, Alexandr O Ivantsov,[...]. Cancer Lett 2015
56
33

Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour.
Giuseppe Piarulli, Florian Puls, Bo Wängberg, Henrik Fagman, Magnus Hansson, Jenny Nilsson, Elsa Arbajian, Fredrik Mertens. Histopathology 2019
11
33

Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samples.
Hideyuki Abe, Akihiko Kawahara, Koichi Azuma, Tomoki Taira, Yorihiko Takase, Chihiro Fukumitsu, Kazuya Murata, Tomohiko Yamaguchi, Jun Akiba, Hidenobu Ishii,[...]. J Thorac Oncol 2015
23
33

Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
Jason C Chang, Lei Zhang, Alexander E Drilon, Ping Chi, Rita Alaggio, Laetitia Borsu, Ryma Benayed, William D Travis, Marc Ladanyi, Cristina R Antonescu. J Thorac Oncol 2019
36
33

5'/ 3' imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer.
Yongqing Tong, Zhijun Zhao, Bei Liu, Anyu Bao, Hongyun Zheng, Jian Gu, Mary McGrath, Ying Xia, Bihua Tan, Chunhua Song,[...]. J Exp Clin Cancer Res 2018
17
33

Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan.
Yi-Cheng Wu, Il-Chi Chang, Chi-Liang Wang, Tai-Di Chen, Ya-Ting Chen, Hui-Ping Liu, Yen Chu, Yu-Ting Chiu, Tzu-Hua Wu, Li-Hui Chou,[...]. PLoS One 2013
79
33

Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer.
David R Hout, Brock L Schweitzer, Kasey Lawrence, Stephan W Morris, Tracy Tucker, Rosetta Mazzola, Rachel Skelton, Frank McMahon, John Handshoe, Mary Lesperance,[...]. Cancers (Basel) 2017
13
33

Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders.
Marianna David, Nicholas C P Cross, Sonja Burgstaller, Andrew Chase, Claire Curtis, Raymond Dang, Martine Gardembas, John M Goldman, Francis Grand, George Hughes,[...]. Blood 2007
112
33

Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.
Jason L Hornick, Lynette M Sholl, Paola Dal Cin, Merrida A Childress, Christine M Lovly. Mod Pathol 2015
43
33

Genomic diagnostics leading to the identification of a TFG-ROS1 fusion in a child with possible atypical meningioma.
Maria Rossing, Christina Westmose Yde, Astrid Sehested, Olga Østrup, David Scheie, Volodia Dangouloff-Ros, Birgit Geoerger, Gilles Vassal, Karsten Nysom. Cancer Genet 2017
10
33

Inflammatory myofibroblastic tumours: where are we now?
B C Gleason, J L Hornick. J Clin Pathol 2008
433
33

Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.
D Ross Camidge, Scott A Kono, Antonella Flacco, Aik-Choon Tan, Robert C Doebele, Qing Zhou, Lucio Crino, Wilbur A Franklin, Marileila Varella-Garcia. Clin Cancer Res 2010
263
33

Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor.
Shijie Mai, Gang Xiong, Dingwei Diao, Wenjing Wang, Yujie Zhou, Ruijun Cai. Lung Cancer 2019
15
33

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
Steven G DuBois, Theodore W Laetsch, Noah Federman, Brian K Turpin, Catherine M Albert, Ramamoorthy Nagasubramanian, Megan E Anderson, Jessica L Davis, Hope E Qamoos, Mark E Reynolds,[...]. Cancer 2018
66
33

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Marina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, Maya Ilouze, Addie Dvir, Theresa Boyle, Murry Wynes, Vincent A Miller, Doron Lipson, Gary A Palmer,[...]. Oncologist 2015
114
33

Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods.
Brian J Haas, Alexander Dobin, Bo Li, Nicolas Stransky, Nathalie Pochet, Aviv Regev. Genome Biol 2019
151
33

Inflammatory Myofibroblastic Tumor Driven by Novel NUMA1-ALK Fusion Responds to ALK Inhibition.
Nisha Rao, Hans Iwenofu, Bingfeng Tang, Jennifer Woyach, David A Liebner. J Natl Compr Canc Netw 2018
21
33


Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
Josh D Haimes, Colin J R Stewart, Brian A Kudlow, Brady P Culver, Bo Meng, Eleanor Koay, Ann Whitehouse, Nichola Cope, Jen-Chieh Lee, Tony Ng,[...]. Am J Surg Pathol 2017
57
33

Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
Kazunori Honda, Shigenori Kadowaki, Kyoko Kato, Nobuhiro Hanai, Yasuhisa Hasegawa, Yasushi Yatabe, Kei Muro. Invest New Drugs 2019
12
33



Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples.
Chao Zhao, Xuefei Li, Jiayu Li, Yishi Zhang, Shengxiang Ren, Xiaoxia Chen, Caicun Zhou. Transl Oncol 2014
20
33

U.S. Food and Drug Administration approval: crizotinib for treatment of advanced or metastatic non-small cell lung cancer that is anaplastic lymphoma kinase positive.
Shakun M Malik, Virginia Ellen Maher, Karen E Bijwaard, Robert L Becker, Lijun Zhang, Shenghui W Tang, Pengfei Song, Qi Liu, Anshu Marathe, Brenda Gehrke,[...]. Clin Cancer Res 2014
106
33

Detection of ALK-positive non-small-cell lung cancers on cytological specimens: high accuracy of immunocytochemistry with the 5A4 clone.
Spasenija Savic, Beata Bode, Joachim Diebold, Ivo Tosoni, Audrey Barascud, Betty Baschiera, Bruno Grilli, Michelle Herzog, Ellen Obermann, Lukas Bubendorf. J Thorac Oncol 2013
73
33

Detection of EGFR and KRAS gene mutations using suspension liquid-based cytology specimens in metastatic lung adenocarcinoma.
Huan Zhao, Tian Qiu, Huiqin Guo, Jianming Ying, Junling Li, Zhihui Zhang. Oncotarget 2017
10
33

ROS1 rearrangements define a unique molecular class of lung cancers.
Kristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine M Lovly, Nerina T McDonald, Pierre P Massion, Christina Siwak-Tapp, Adriana Gonzalez, Rong Fang,[...]. J Clin Oncol 2012
33

The evolving genomic classification of lung cancer.
David S Shames, Ignacio I Wistuba. J Pathol 2014
68
33

The value of cell block based on fine needle aspiration for lung cancer diagnosis.
Zhengwei Dong, Hui Li, Jun Zhou, Wei Zhang, Chunyan Wu. J Thorac Dis 2017
13
33

Anaplastic lymphoma kinase rearrangements in non-small-cell lung cancer: novel applications in diagnostics and treatment.
Rodney E Shackelford, Junaid M Ansari, Eric X Wei, Jonathan S Alexander, James Cotelingam. Pharmacogenomics 2017
4
33

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. Arch Pathol Lab Med 2013
324
33

ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.
Pasquale Pisapia, Maria D Lozano, Elena Vigliar, Claudio Bellevicine, Francesco Pepe, Umberto Malapelle, Giancarlo Troncone. Cancer Cytopathol 2017
31
33

Non-small-cell lung cancer: then and now.
Joan H Schiller, David R Gandara, Glenwood D Goss, Everett E Vokes. J Clin Oncol 2013
25
33

ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients.
Cecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, Anna Squadrilli, Costanza Lagrasta, Sebastiano Buti, Donatello Gasparro, Daniele Zanoni, Maria Majori, Massimo De Filippo,[...]. Diagn Cytopathol 2015
40
33

ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.
Yunjian Pan, Yang Zhang, Yuan Li, Haichuan Hu, Lei Wang, Hang Li, Rui Wang, Ting Ye, Xiaoyang Luo, Yiliang Zhang,[...]. Lung Cancer 2014
146
33


Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
Sun Min Lim, Hye Ryun Kim, Jong-Seok Lee, Ki Hyeong Lee, Yun-Gyoo Lee, Young Joo Min, Eun Kyung Cho, Sung Sook Lee, Bong-Seog Kim, Moon Young Choi,[...]. J Clin Oncol 2017
168
33

Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements.
Cristina Teixidó, Niki Karachaliou, Vicente Peg, Ana Gimenez-Capitan, Rafael Rosell. Transl Lung Cancer Res 2014
47
33

Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.
Yudong Su, Xiang Long, Yang Song, Peng Chen, Shanqing Li, Huaxia Yang, Pancheng Wu, Yanyu Wang, Zhongxing Bing, Zhili Cao,[...]. Target Oncol 2019
22
33

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
Thomas J Lynch, Daphne W Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A Okimoto, Brian W Brannigan, Patricia L Harris, Sara M Haserlat, Jeffrey G Supko, Frank G Haluska,[...]. N Engl J Med 2004
33

Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis.
Shumeng Zhang, Bing Yan, Jing Zheng, Jing Zhao, Jianying Zhou. Oncotarget 2016
4
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.